Sanara MedTech (SMTI) Income from Non-Controlling Interests (2019 - 2026)
Sanara MedTech (SMTI) posted Income from Non-Controlling Interests of -$354.0 for Q1 2026, down 45.08% on a QoQ basis from -$244.0 in Q4 2025, and down 71.84% year-over-year from -$1257.3 in Q1 2025.
Sanara MedTech (SMTI) Income from Non-Controlling Interests (2019 - 2026) Analysis & Trends
Sanara MedTech's Income from Non-Controlling Interests history runs 8 years deep, the most recent figure standing at -$354.0 for Q1 2026.
- Quarterly Income from Non-Controlling Interests fell 71.84% year-over-year to -$354.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5589.0 (up 98.08% YoY) and the FY2025 annual result came in at -$5441.0, up 97.77% from the prior year.
- Income from Non-Controlling Interests was -$354.0 for Q1 2026 at Sanara MedTech, down from -$244.0 in the prior quarter.
- Across five years, Income from Non-Controlling Interests topped out at $242000.0 in Q4 2022 and bottomed at -$240903.0 in Q4 2024.
- A 5-year average of -$19130.5 and a median of -$25250.0 in 2023 frame the typical range for Income from Non-Controlling Interests.
- Annual changes were most pronounced in 2022 — Income from Non-Controlling Interests jumped 3023.76% — and 2024, when it slumped 854.07%.
- Sanara MedTech's Income from Non-Controlling Interests stood at $242000.0 in 2022, then slumped by 110.43% to -$25250.0 in 2023, then slumped by 854.07% to -$240903.0 in 2024, then surged by 99.9% to -$244.0 in 2025, then sank by 45.08% to -$354.0 in 2026.
- Business Quant data shows SMTI's Income from Non-Controlling Interests at -$354.0 in Q1 2026, -$244.0 in Q4 2025, and -$955.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | -18.70 Mn |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | - |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | - |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | 110.00 Mn |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | - |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | - |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | - |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | - |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | - |
| 10 | Sanara MedTech | 228.72 Mn | 215.13 Mn | 25.87 Mn | -354.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -354.00 |
| Dec 31, 2025 | -244.00 |
| Sep 30, 2025 | -955.00 |
| Jun 30, 2025 | -4,036.00 |
| Mar 31, 2025 | -206.00 |
| Dec 31, 2024 | -240,903.00 |
| Sep 30, 2024 | -25,284.00 |
| Jun 30, 2024 | -25,188.00 |
| Mar 31, 2024 | -34,859.00 |
| Dec 31, 2023 | -25,250.00 |
| Sep 30, 2023 | -34,579.00 |
| Jun 30, 2023 | -38,447.00 |
| Mar 31, 2023 | -38,429.00 |
| Dec 31, 2022 | 242,000.00 |
| Sep 30, 2022 | -58,792.00 |
| Jun 30, 2022 | -12,512.00 |
| Mar 31, 2022 | -27,181.00 |
| Dec 31, 2021 | -8,277.00 |
| Sep 30, 2021 | -27,491.00 |
| Jun 30, 2021 | -34,481.00 |